Difficulty: Medium
Average Score: 76%
Practice
Which drug reduces urine volume in both pituitary and renal diabetes insipidus and is orally active?
Correct answer
C
Rationale
In this question, the correct answer is C) Chlorpropamide. Chlorpropamide is a sulfonylurea drug that reduces urine volume in both pituitary and renal diabetes insipidus by enhancing the action of antidiuretic hormone (ADH) in the kidneys.
A) Vasopressin is the synthetic form of ADH and is used to treat diabetes insipidus by replacing the hormone that is lacking. It does not directly reduce urine volume in both types of diabetes insipidus.
B) Hydrochlorothiazide is a diuretic that increases urine volume by promoting water excretion from the body. It is not used to treat diabetes insipidus.
D) Carbamazepine is an anticonvulsant drug and is not indicated for the treatment of diabetes insipidus.
Educational Context:
Understanding the mechanisms of action of different drugs used in the treatment of diabetes insipidus is crucial for healthcare professionals, especially pharmacology students. Knowing the specific actions of each drug helps in making appropriate treatment decisions based on the type and cause of diabetes insipidus in a patient. It also highlights the importance of drug selection based on the underlying pathophysiology of the condition.
A) Vasopressin is the synthetic form of ADH and is used to treat diabetes insipidus by replacing the hormone that is lacking. It does not directly reduce urine volume in both types of diabetes insipidus.
B) Hydrochlorothiazide is a diuretic that increases urine volume by promoting water excretion from the body. It is not used to treat diabetes insipidus.
D) Carbamazepine is an anticonvulsant drug and is not indicated for the treatment of diabetes insipidus.
Educational Context:
Understanding the mechanisms of action of different drugs used in the treatment of diabetes insipidus is crucial for healthcare professionals, especially pharmacology students. Knowing the specific actions of each drug helps in making appropriate treatment decisions based on the type and cause of diabetes insipidus in a patient. It also highlights the importance of drug selection based on the underlying pathophysiology of the condition.